Publications by authors named "Anthony L Vaccarino"

21Publications

Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatment.

J Psychiatr Res 2019 03 8;110:38-44. Epub 2018 Dec 8.

Department of Pathology and Molecular Medicine, Queen's University, RM 401, Richardson Lab, 88 Stuart St., Kingston, Ontario, K7L 3N6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2018.12.007DOI Listing
March 2019

The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder.

Innov Clin Neurosci 2016 Sep-Oct;13(9-10):20-31. Epub 2016 Oct 1.

Dr. Vaccarino is with Indoc Research, Toronto, Ontario, Canada; Dr. Evans is with Indoc Research, Toronto, Ontario, Canada, and Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada; Dr. Kalali is with Quintiles Inc, San Diego, California, USA, and Department of Psychiatry, University of California, San Diego, California, USA; Drs. Kennedy and Placenza are with University Health Network, Toronto, Ontario, Canada; Dr. Engelhardt is with Cronos Clinical Consulting Services, Lambertville, New Jersey, USA; Dr. Frey is with Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada, and Mood Disorders Program and Women's Health Concerns Clinic, St. Joseph's Healthcare, Hamilton, Ontario, Canada; Dr. Greist is with Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; Dr. Kobak is with Center for Telepsychology, Madison, Wisconsin, USA; Dr. Lam is with Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada; Dr. MacQueen is with Mathison Centre for Mental Health Research and Education, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada; Dr. Milev is with Department of Psychiatry, Queen's University, Kingston, Ontario, Canada; Dr. Ravindran is with Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada, and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Dr. Sheehan is with Department of Psychiatry and Behavioral Health, University of South Florida College of Medicine, Tampa, Florida, USA; Dr. Sills was with OCBN, Toronto, Ontario, Canada; Dr. Williams is with Columbia University, New York, New York, USA, and Medavante Inc., Trenton, New Jersey, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141593PMC
October 2016

Assessment of cognitive symptoms in prodromal and early huntington disease.

PLoS Curr 2011 Oct 25;3:RRN1250. Epub 2011 Oct 25.

Research Methods, Ontario Cancer Biomarker Network, Toronto, Ontario, Canada; Department of Psychiatry and Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD USA; Translational Medicine, CHDI Foundation, Inc., Princeton NJ; University of Manchester, Manchester Academic Health Sciences Centre and Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; CHDI Foundation, Inc.; Huntington's Disease Drug Works, Lake Forest Park, WA; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario Canada; School of Psychology and Clinical Language Sciences, University of Reading, U.K.; Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA, USA; School of Psychology and Psychiatry, Monash University, Melbourne, Australia and CNS Drug Development consultant.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201666PMC
October 2011

Assessment of Day-to-Day Functioning in Prodromal and Early Huntington Disease.

PLoS Curr 2011 Sep 12;3:RRN1262. Epub 2011 Sep 12.

Research Methods, Ontario Cancer Biomarker Network, Toronto, Ontario, Canada; Department of Psychiatry and Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York; CHDI Foundation, Inc.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario Canada; School of Psychology and Clinical Language Sciences, University of Reading, U.K.; Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA, USA; Department of Biostatistics, CHDI Foundation, Princeton NJ USA and College of Nursing, The University of Iowa, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1262DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172089PMC
September 2011

Self Reports of Day-to-Day Function in a Small Cohort of People with Prodromal and Early HD.

PLoS Curr 2011 Aug 11;3:RRN1254. Epub 2011 Aug 11.

College of Nursing, The University of Iowa, Iowa City, IA; Research Methods, Ontario Cancer Biomarker Network, Toronto, Ontario, Canada; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario Canada and Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154838PMC
August 2011

Assessment of depression, anxiety and apathy in prodromal and early huntington disease.

PLoS Curr 2011 Jun 17;3:RRN1242. Epub 2011 Jun 17.

Research Methods, Ontario Cancer Biomarker Network, Toronto, Ontario, Canada; Department of Psychiatry and Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD USA; AP-HP, centre de référence maladie de Huntington; INSERM U955 E01- Ecole Normale Supérieure-University Paris Est, Neuropsychologie interventionnelle laboratory,Créteil- Paris, France; Translational Medicine, CHDI Foundation, Inc., Princeton NJ; University of Manchester, Manchester Academic Health Sciences Centre and Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; Neurology, University of Utah, Salt Lake City UT USA; CHDI Foundation, Inc.; Departments of Neurology and Psychiatry, Beth Israel Medical Center, New York, NY; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario Canada; School of Psychology and Clinical Language Sciences, University of Reading, U.K.; Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA, USA; The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway & Department of Neurology, Stavanger University Hospital, Stavanger, Norway; Department of Psychiatry, Leiden University Medical Centre, Leiden, Netherlands and CNS Drug Development consultant.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1242DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124013PMC
June 2011

Assessing onset of treatment benefit in depression and anxiety: conceptual considerations.

J Clin Psychiatry 2009 Aug;70(8):1138-45

New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.09cs05129DOI Listing
August 2009

Multiple pain complaints in patients with major depressive disorder.

Psychosom Med 2009 Feb 10;71(2):159-62. Epub 2008 Dec 10.

Ontario Cancer Biomarker Network, MaRS Centre, South Tower, 101 College Street, Suite 200, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PSY.0b013e3181906572DOI Listing
February 2009

Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.

Depress Anxiety 2008 ;25(12):1006-13

International Society for CNS Drug Development, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/da.20435DOI Listing
March 2009

Evaluation of morphine analgesia and motor coordination in mice following cortex-specific knockout of the N-methyl-D-aspartate NR1-subunit.

Neurosci Lett 2008 May 30;437(1):55-8. Epub 2008 Mar 30.

Neuroscience Center of Excellence, Louisiana State University Health Science Center, New Orleans, LA 70112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2008.03.077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2497425PMC
May 2008

Prevalence and association of somatic symptoms in patients with Major Depressive Disorder.

J Affect Disord 2008 Oct 15;110(3):270-6. Epub 2008 Feb 15.

International Society for CNS Drug Development, MaRS Center, South Tower, 101 College Street, Suite 200, Toronto, ON, Canada M5G 1L7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2008.01.009DOI Listing
October 2008

Decreased pain response in mice following cortex-specific knockout of the N-methyl-D-aspartate NR1 subunit.

Neurosci Lett 2007 Sep 19;425(2):89-93. Epub 2007 Aug 19.

Neuroscience Center of Excellence, Louisiana State University Health Science Center, New Orleans, LA 70112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2007.08.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670823PMC
September 2007

Synthesis and in vivo evaluation of non-hepatotoxic acetaminophen analogs.

Bioorg Med Chem 2007 Mar 21;15(5):2206-15. Epub 2006 Aug 21.

Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S096808960600608
Publisher Site
http://dx.doi.org/10.1016/j.bmc.2006.07.054DOI Listing
March 2007